Income Statement
CYTOSORBENTS CORP
CTSO
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - | - | - | 22.50 | 15.15 | 9.53 | 4.79 | 4.12 | 2.42 | 1.34 | 0.04 |
|
Cost of Revenue
|
10.57 | -13.96 | 13.96 | 13.96 | 11.05 | 11.05 | 7.36 | 7.49 | - | - | - | - | - | - | - |
|
Gross Profit
|
26.49 | 25.13 | 22.39 | 20.73 | 32.12 | 29.95 | 17.59 | 15.01 | 9.63 | 5.57 | 2.58 | 1.99 | 0.51 | 1.02 | 0.02 |
|
Operating Expenses
|
41.24 | 53.60 | 53.60 | 52.25 | 54.86 | 40.32 | 36.56 | 30.60 | 19.47 | 17.07 | 11.88 | 9.27 | 5.22 | 4.51 | 4.46 |
|
Research & Development
|
- | - | 15.73 | 15.12 | 16.38 | 8.81 | 12.09 | 7.72 | 4.05 | 4.78 | 3.87 | 2.43 | 1.74 | 2.53 | 2.89 |
|
Selling, General & Administrative
|
35.65 | 37.87 | 33.60 | 34.29 | 35.75 | 28.46 | 22.01 | 20.87 | 14.09 | 11.10 | 6.92 | 5.55 | 2.58 | 1.35 | 1.23 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
-14.75 | -28.48 | -31.21 | -31.52 | -22.74 | -10.37 | -18.97 | -15.58 | -9.84 | -11.49 | -9.30 | -7.28 | -4.71 | -3.49 | -4.44 |
|
Non-Operating Income
|
6.15 | -5.62 | 1.89 | -2.38 | -2.55 | 1.41 | -1.38 | -2.25 | 0.71 | -0.77 | 0.85 | -2.43 | -0.42 | -0.56 | -1.04 |
|
Interest Income
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Interest Expense
|
- | - | - | - | 0.08 | 0.25 | 0.08 | 0.07 | 0.05 | 0.02 | 0.00 | 0.20 | - | 0.24 | - |
|
Other Non-Op Income / Expense
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Income Before Tax
|
-8.60 | -22.41 | -29.32 | -33.91 | -25.29 | -8.96 | -20.36 | -17.83 | -9.14 | -12.26 | -8.46 | -9.71 | -5.14 | -4.06 | -5.48 |
|
Income Tax Expense
|
-0.40 | -1.69 | -0.81 | -1.09 | -0.74 | -1.13 | -1.09 | -17.83 | -9.14 | -12.26 | -8.46 | -0.39 | -0.46 | -0.39 | 0.00 |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Net Income
|
-8.20 | -20.72 | -28.51 | -32.81 | -24.56 | -7.84 | -19.27 | 0.00 | 0.00 | 0.00 | 0.00 | 9.32 | 4.68 | -3.66 | -5.48 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-13.52 | -26.91 | -29.75 | -30.64 | -22.01 | -9.71 | -18.39 | -15.19 | -9.62 | -11.33 | -9.19 | -7.21 | -4.65 | -3.44 | -4.40 |
|
Earnings Per Share (Basic)
|
-0.13 | -0.38 | -0.64 | -0.75 | -0.57 | - | - | - | - | - | - | - | - | - | - |
|
Diluted EPS
|
-0.13 | -0.38 | -0.64 | -0.75 | -0.57 | - | - | - | - | - | - | - | - | - | - |
|
Weighted Average Shares
|
62.23 | 54.43 | 44.66 | 43.57 | 43.36 | - | - | - | - | - | - | - | - | - | - |
|
Diluted Weighted Avg Shares
|
62.23 | 54.43 | 44.66 | 43.57 | 43.36 | - | - | - | - | - | - | - | - | - | - |
|
Comprehensive Income
|
-15.43 | -16.69 | -30.31 | -31.01 | -22.30 | -10.10 | -19.03 | -16.56 | -9.72 | -11.62 | -7.78 | -9.04 | -4.72 | -3.68 | - |